Swedish Orphan Biovitrum AB (SOBIN) Q3 2023 Earnings Report
MX:SOBIN Q3 2023 EPS Results
- Actual EPS
- MXN 1.04
- Consensus EPS
- MXN 0.71
- Beat/Miss
- Beat by +MXN 0.33
- One Year Ago EPS
- MXN 2.79
MX:SOBIN Q3 2023 Revenue Results
- Actual Revenue
- MXN 9.93B
- Expected Revenue
- MXN 8.75B
- Beat/Miss
- Beat by +MXN 1.19B
- YoY Revenue Growth
- +29.23%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 10/30/2023
- Time
- Before Open
- Conference Call
- Monday, October 30, 2023
MX:SOBIN Upcoming Earnings
Swedish Orphan Biovitrum AB's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:SOBIN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 12.74- | 10.36 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 11.5612.86 | -15.99 | 180.41% (+28.84) | |
| Jul 16, 2026 | 2026 (Q2) | 6.536.03 | 3.52 | 71.58% (+2.52) | |
| Apr 28, 2026 | 2026 (Q1) | 6.987.32 | 4.9 | 49.41% (+2.42) | |
| Feb 05, 2026 | 2025 (Q4) | 8.1110.36 | 7.82 | 32.43% (+2.54) | |
| Oct 20, 2025 | 2025 (Q3) | 8.94-15.99 | 8.21 | -294.85% (-24.19) | |
| Jul 16, 2025 | 2025 (Q2) | 3.233.52 | 1.27 | 177.27% (+2.25) | |
| Apr 29, 2025 | 2025 (Q1) | 4.174.90 | 4.52 | 8.51% (+0.38) | |
| Feb 05, 2025 | 2024 (Q4) | 6.907.82 | 5.8 | 34.77% (+2.02) | |
| Oct 24, 2024 | 2024 (Q3) | 4.248.21 | 1.04 | 690.74% (+7.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
